Columbia University College of Physicians and Surgeons, New York, NY 10032, USA.
J Clin Oncol. 2012 Mar 10;30(8):783-91. doi: 10.1200/JCO.2011.36.7508. Epub 2012 Jan 30.
Use of robotics in oncologic surgery is increasing; however, reports of safety and efficacy are from highly experienced surgeons and centers. We performed a population-based analysis to compare laparoscopic hysterectomy and robotic hysterectomy for endometrial cancer.
The Perspective database was used to identify women who underwent a minimally invasive hysterectomy for endometrial cancer from 2008 to 2010. Morbidity, mortality, and cost were evaluated using multivariable logistic and linear regression models.
We identified 2,464 women, including 1,027 (41.7%) who underwent laparoscopic hysterectomy and 1,437 (58.3%) who underwent robotic hysterectomy. Women treated at larger hospitals, nonteaching hospitals, and centers outside of the northeast were more likely to undergo a robotic hysterectomy procedure, whereas black women, those without insurance, and women in rural areas were less likely to undergo a robotic hysterectomy procedure (P < .05 for all). The overall complication rate was 9.8% for laparoscopic hysterectomy versus 8.1% for robotic hysterectomy (P = .13). The adjusted odds ratio (OR) for any morbidity for robotic hysterectomy was 0.76 (95% CI, 0.56 to 1.03). After adjusting for patient, surgeon, and hospital characteristics, there were no significant differences in the rates of intraoperative complications (OR, 0.68; 95% CI, 0.42 to 1.08), surgical site complications (OR, 1.49; 95% CI, 0.81 to 2.73), medical complications (OR, 0.64; 95% CI, 0.40 to 1.01), or prolonged hospitalization (OR, 0.85; 95% CI, 0.64 to 1.14) between the procedures. The mean cost for robotic hysterectomy was $10,618 versus $8,996 for laparoscopic hysterectomy (P < .001). In a multivariable model, robotic hysterectomy was significantly more costly ($1,291; 95% CI, $985 to $1,597).
Despite claims of decreased complications with robotic hysterectomy, we found similar morbidity but increased cost compared with laparoscopic hysterectomy. Comparative long-term efficacy data are needed to justify its widespread use.
机器人在肿瘤外科中的应用正在增加;然而,安全性和疗效的报告来自经验丰富的外科医生和中心。我们进行了一项基于人群的分析,比较了腹腔镜子宫切除术和机器人子宫切除术治疗子宫内膜癌。
使用 Perspective 数据库确定 2008 年至 2010 年间接受微创子宫内膜癌子宫切除术的女性。使用多变量逻辑和线性回归模型评估发病率、死亡率和成本。
我们共确定了 2464 名女性,其中 1027 名(41.7%)接受了腹腔镜子宫切除术,1437 名(58.3%)接受了机器人子宫切除术。在较大的医院、非教学医院和东北部以外的中心接受治疗的女性更有可能接受机器人子宫切除术,而黑人女性、没有保险的女性和农村地区的女性接受机器人子宫切除术的可能性较小(所有 P<.05)。腹腔镜子宫切除术的总体并发症发生率为 9.8%,而机器人子宫切除术为 8.1%(P=.13)。机器人子宫切除术任何并发症的调整后优势比(OR)为 0.76(95%CI,0.56 至 1.03)。调整患者、外科医生和医院特征后,术中并发症发生率(OR,0.68;95%CI,0.42 至 1.08)、手术部位并发症发生率(OR,1.49;95%CI,0.81 至 2.73)、医疗并发症发生率(OR,0.64;95%CI,0.40 至 1.01)或住院时间延长(OR,0.85;95%CI,0.64 至 1.14)无显著差异。机器人子宫切除术的平均费用为 10618 美元,而腹腔镜子宫切除术为 8996 美元(P<.001)。在多变量模型中,机器人子宫切除术的费用显著更高(1291 美元;95%CI,985 美元至 1597 美元)。
尽管有报道称机器人子宫切除术的并发症减少,但我们发现其发病率相似,但与腹腔镜子宫切除术相比,成本增加。需要比较长期疗效数据来证明其广泛应用的合理性。